Recommendations for the management of tyrosinaemia type 1.

174Citations
Citations of this article
169Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The management of tyrosinaemia type 1 (HT1, fumarylacetoacetase deficiency) has been revolutionised by the introduction of nitisinone but dietary treatment remains essential and the management is not easy. In this review detailed recommendations for the management are made based on expert opinion, published case reports and investigational studies as the evidence base is limited and there are no prospective controlled studies.The added value of this paper is that it summarises in detail current clinical knowledge about HT1 and makes recommendations for the management.

Cite

CITATION STYLE

APA

de Laet, C., Dionisi-Vici, C., Leonard, J. V., McKiernan, P., Mitchell, G., Monti, L., … Spiekerkötter, U. (2013). Recommendations for the management of tyrosinaemia type 1. Orphanet Journal of Rare Diseases. https://doi.org/10.1186/1750-1172-8-8

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free